Davidson Kempner Capital Management »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $34M 35M 0.98
2023-09-30 $28M 30M 0.92

More positions owned by Davidson Kempner Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arko Corp (ARKO)
Kenvue (KVUE)
Joyy Note 1.375% 6/1 (Principal)
Pdd Holdings Note 12/0 (Principal)
Wayfair Note 3.250% 9/1 (Principal)
Vnet Group Note 2/0 (Principal)
Playa Hotels & Resorts Nv SHS (PLYA)
Metropcs Communications (TMUS)
Meta Platforms Cl A (META)
Amazon (AMZN)
Redfin Corp Note 0.500% 4/0 (Principal)
Linde SHS (LIN)
Angel Oak Mtg (AOMR)
Li Auto Note 0.250% 5/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Calamos Advisors
Steelhead Partners
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Capstone Investment Advisors
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1